Nautilus Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Nautilus Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$336K	Buy	+6,550	New	+$333K	0.2%	123

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Nautilus Advisors's IHI Position: Q2 2026 in Review

Nautilus Advisors opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 6,550 shares worth $336K. The stake represents 0.2% of the portfolio and ranks #123 among its holdings.

502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Nautilus Advisors held 6,550 shares of iShares US Medical Devices ETF worth $336K as of Q2 2026.
iShares US Medical Devices ETF was a new Nautilus Advisors position in Q2 2026.
iShares US Medical Devices ETF made up 0.2% of Nautilus Advisors's portfolio in Q2 2026, its #123 holding.
502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.